REGN vs SCI
Regeneron Pharmaceuticals Inc (REGN) versus Service Corporation International (SCI) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Service Corporation International (SCI) is a personal services company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SCI revenue for 2025-12-31 was $4.31B. Net income was $542.6M. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. SCI currently screens at market cap $10.01B and trailing P/E 19.1.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SCI currently screens at market cap $10.01B and trailing P/E 19.1.
Not investment advice. Open the REGN and SCI stock pages for the full models.
Not investment advice.